Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block
Comparison of the Therapeutic Efficacy and Safety of Ultrasound-guided Cervical Selective Nerve Root Block and Fluoroscopic Guided Cervical Transforaminal Epidural Block in Patients With Cervical Radiculopathy: A Retrospective Study
1 other identifier
interventional
330
1 country
1
Brief Summary
This study retrospectively analyzed medical records and imaging records (ultrasound images, fluoroscopy-guided images) of US-CSNRB and FL-CTFEB procedures performed at the Yangsan Pusan National University Hospital Pain Clinic outpatient department from May 1, 2019, to April 30, 2024. It compared the therapeutic effects (pain reduction), procedure-related indicators (comparison of contrast agent spread), safety (incidence of complications), and changes in analgesic usage. The primary outcome of this study is the difference in pain chage (Visual Analogue Scale, VAS) between patients undergoing US-CSNRB and FL-CTFEB. The secondary outcomes are comparison of contrast agent spread and comparison of procedure-related complication rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 22, 2025
CompletedFirst Submitted
Initial submission to the registry
February 21, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2026
CompletedMarch 3, 2026
February 1, 2026
4 months
February 21, 2026
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference in pain change
the difference in pain change, assessed using the visual analogue scale (VAS), between patients who underwent US-CSNRB and those who underwent FL-CTFEB
baseline, 1 month, 2 month, 3 month
Secondary Outcomes (2)
The pattern of contrast spread
periprocedural
The incidence of procedure-related complications
Periprocedural
Study Arms (2)
group U
EXPERIMENTALgroup F
ACTIVE COMPARATORInterventions
A patient presenting to the pain clinic with cervical neck pain and upper extremity radicular pain, whose symptoms did not improve with medication, demonstrated a positive Spurling test on physical examination, and showed cervical radiculopathy at the C3/4 to C7/T1 level on imaging studies (CT or MRI), underwent an ultrasound-guided cervical selective nerve root block
A patient presenting to the pain clinic with cervical neck pain and upper extremity radicular pain, whose symptoms did not improve with medication, demonstrated a positive Spurling test on physical examination, and showed cervical radiculopathy at the C3/4 to C7/T1 level on imaging studies (CT or MRI), underwent a fluoroscopy-guided cervical transforaminal epidural block
Eligibility Criteria
You may qualify if:
- Adult male and female patients aged 18 years or older.
- Patients diagnosed with cervical radiculopathy who underwent US-guided or FL-guided procedures.
- Patients with clearly documented pain scale (VAS) assessments in medical records at the following time points: 1st visit (before the procedure), 2nd visit, 3rd visit, and at least 3 months post-procedure.
- Patients who underwent procedures for lesions in a single or adjacent two segments.
You may not qualify if:
- Patients who underwent surgical treatment within one month after the procedure due to progressive neurological deficits.
- Patients with severe systemic diseases (e.g., cancer, severe immunosuppressive disorders) that may affect pain assessment.
- Patients with severe systemic diseases (e.g., cancer, severe immunosuppressive disorders) that may affect pain assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 21, 2026
First Posted
March 3, 2026
Study Start
December 22, 2025
Primary Completion
May 4, 2026
Study Completion
May 4, 2026
Last Updated
March 3, 2026
Record last verified: 2026-02